Selected research
Market Outlook & Growth Opportunities
Global DNA-Encoded Library Screening Services Market Outlook and Growth Opportunities 2026
Market perspective
The global DNA-Encoded Library Screening Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for DNA-Encoded Library Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for DNA-Encoded Library Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA-Encoded Library Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the DNA-Encoded Library Screening Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the DNA-Encoded Library Screening Services market include Pharmaron, Vipergen, Novalix, DyNAbind, MedChemExpress, BioDuro-Sundia, Charles River Laboratories, Chemspace and X-Chem, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global DNA-Encoded Library Screening Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of DNA-Encoded Library Screening Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DNA-Encoded Library Screening Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA-Encoded Library Screening Services market.
DNA-Encoded Library Screening Services Segment by Company
Pharmaron
Vipergen
Novalix
DyNAbind
MedChemExpress
BioDuro-Sundia
Charles River Laboratories
Chemspace
X-Chem
HitGen
WuXi AppTec
DNA-Encoded Library Screening Services Segment by Type
Provider-Owned Library Screening
Client-Provided Library Screening
Custom-Built Library Screening
Consortium or Shared-Access Library Screening
DNA-Encoded Library Screening Services Segment by Application
Oncology Drug Discovery
Immunology and Inflammation Drug Discovery
Neurology Drug Discovery
Infectious Disease Drug Discovery
Metabolic and Cardiovascular Drug Discovery
Other Therapeutic Discovery
DNA-Encoded Library Screening Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global DNA-Encoded Library Screening Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the DNA-Encoded Library Screening Services key companies, revenue, market share, and recent developments.
3. To split the DNA-Encoded Library Screening Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions DNA-Encoded Library Screening Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify DNA-Encoded Library Screening Services significant trends, drivers, influence factors in global and regions.
6. To analyze DNA-Encoded Library Screening Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA-Encoded Library Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA-Encoded Library Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA-Encoded Library Screening Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA-Encoded Library Screening Services industry.
Chapter 3: Detailed analysis of DNA-Encoded Library Screening Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of DNA-Encoded Library Screening Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of DNA-Encoded Library Screening Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. DNA-Encoded Library Screening Services Industry Trends
Table 2. DNA-Encoded Library Screening Services Industry Drivers
Table 3. DNA-Encoded Library Screening Services Industry Opportunities and Challenges
Table 4. DNA-Encoded Library Screening Services Industry Restraints
Table 5. Global DNA-Encoded Library Screening Services Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global DNA-Encoded Library Screening Services Revenue Share by Company (2021-2026)
Table 7. Global DNA-Encoded Library Screening Services Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global DNA-Encoded Library Screening Services Key Company Manufacturing Base & Headquarters
Table 9. Global DNA-Encoded Library Screening Services Company, Product Type & Application
Table 10. Global DNA-Encoded Library Screening Services Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global DNA-Encoded Library Screening Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Provider-Owned Library Screening
Table 15. Significant Companies of Client-Provided Library Screening
Table 16. Significant Companies of Custom-Built Library Screening
Table 17. Significant Companies of Consortium or Shared-Access Library Screening
Table 18. Global DNA-Encoded Library Screening Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 19. Global DNA-Encoded Library Screening Services Sales Value by Type (2021-2026) & (US$ Million)
Table 20. Global DNA-Encoded Library Screening Services Sales Value by Type (2027-2032) & (US$ Million)
Table 21. Global DNA-Encoded Library Screening Services Sales Value Share by Type (2021-2026)
Table 22. Global DNA-Encoded Library Screening Services Sales Value Share by Type (2027-2032)
Table 23. Significant Companies of Oncology Drug Discovery
Table 24. Significant Companies of Immunology and Inflammation Drug Discovery
Table 25. Significant Companies of Neurology Drug Discovery
Table 26. Significant Companies of Infectious Disease Drug Discovery
Table 27. Significant Companies of Metabolic and Cardiovascular Drug Discovery
Table 28. Significant Companies of Other Therapeutic Discovery
Table 29. Global DNA-Encoded Library Screening Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global DNA-Encoded Library Screening Services Sales Value by Application (2021-2026) & (US$ Million)
Table 31. Global DNA-Encoded Library Screening Services Sales Value by Application (2027-2032) & (US$ Million)
Table 32. Global DNA-Encoded Library Screening Services Sales Value Share by Application (2021-2026)
Table 33. Global DNA-Encoded Library Screening Services Sales Value Share by Application (2027-2032)
Table 34. Global DNA-Encoded Library Screening Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global DNA-Encoded Library Screening Services Sales Value by Region (2021-2026) & (US$ Million)
Table 36. Global DNA-Encoded Library Screening Services Sales Value Share by Region (2021-2026)
Table 37. Global DNA-Encoded Library Screening Services Sales Value by Region (2027-2032) & (US$ Million)
Table 38. Global DNA-Encoded Library Screening Services Sales Value Share by Region (2027-2032)
Table 39. Global DNA-Encoded Library Screening Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. Global DNA-Encoded Library Screening Services Sales Value by Country (2021-2026) & (US$ Million)
Table 41. Global DNA-Encoded Library Screening Services Sales Value Market Share by Country (2021-2026)
Table 42. Global DNA-Encoded Library Screening Services Sales Value by Country (2027-2032) & (US$ Million)
Table 43. Global DNA-Encoded Library Screening Services Sales Value Market Share by Country (2027-2032)
Table 44. Pharmaron Company Information
Table 45. Pharmaron Business Overview
Table 46. Pharmaron DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Pharmaron DNA-Encoded Library Screening Services Product Portfolio
Table 48. Pharmaron Recent Development
Table 49. Vipergen Company Information
Table 50. Vipergen Business Overview
Table 51. Vipergen DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 52. Vipergen DNA-Encoded Library Screening Services Product Portfolio
Table 53. Vipergen Recent Development
Table 54. Novalix Company Information
Table 55. Novalix Business Overview
Table 56. Novalix DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 57. Novalix DNA-Encoded Library Screening Services Product Portfolio
Table 58. Novalix Recent Development
Table 59. DyNAbind Company Information
Table 60. DyNAbind Business Overview
Table 61. DyNAbind DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. DyNAbind DNA-Encoded Library Screening Services Product Portfolio
Table 63. DyNAbind Recent Development
Table 64. MedChemExpress Company Information
Table 65. MedChemExpress Business Overview
Table 66. MedChemExpress DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. MedChemExpress DNA-Encoded Library Screening Services Product Portfolio
Table 68. MedChemExpress Recent Development
Table 69. BioDuro-Sundia Company Information
Table 70. BioDuro-Sundia Business Overview
Table 71. BioDuro-Sundia DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. BioDuro-Sundia DNA-Encoded Library Screening Services Product Portfolio
Table 73. BioDuro-Sundia Recent Development
Table 74. Charles River Laboratories Company Information
Table 75. Charles River Laboratories Business Overview
Table 76. Charles River Laboratories DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. Charles River Laboratories DNA-Encoded Library Screening Services Product Portfolio
Table 78. Charles River Laboratories Recent Development
Table 79. Chemspace Company Information
Table 80. Chemspace Business Overview
Table 81. Chemspace DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. Chemspace DNA-Encoded Library Screening Services Product Portfolio
Table 83. Chemspace Recent Development
Table 84. X-Chem Company Information
Table 85. X-Chem Business Overview
Table 86. X-Chem DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. X-Chem DNA-Encoded Library Screening Services Product Portfolio
Table 88. X-Chem Recent Development
Table 89. HitGen Company Information
Table 90. HitGen Business Overview
Table 91. HitGen DNA-Encoded Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 92. HitGen DNA-Encoded Library Screening Services Product Portfolio
Table 93. HitGen Recent Development
Table 94. WuXi AppTec Company Information
Table 95. WuXi AppTec Business Overview
Table 96. WuXi AppTec DNA-Encoded Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 97. WuXi AppTec DNA-Encoded Library Screening Services Product Portfolio
Table 98. WuXi AppTec Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Authors List of This Report
Table 101. Secondary Sources
Table 102. Primary Sources
List of Figures
Figure 1. DNA-Encoded Library Screening Services Product Image
Figure 2. Global DNA-Encoded Library Screening Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global DNA-Encoded Library Screening Services Market Size (2021-2032) & (US$ Million)
Figure 4. Global DNA-Encoded Library Screening Services Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Provider-Owned Library Screening Image
Figure 8. Client-Provided Library Screening Image
Figure 9. Custom-Built Library Screening Image
Figure 10. Consortium or Shared-Access Library Screening Image
Figure 11. Global DNA-Encoded Library Screening Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global DNA-Encoded Library Screening Services Sales Value Share 2021 VS 2025 VS 2032
Figure 13. Global DNA-Encoded Library Screening Services Sales Value Share by Type (2021-2032)
Figure 14. Oncology Drug Discovery Image
Figure 15. Immunology and Inflammation Drug Discovery Image
Figure 16. Neurology Drug Discovery Image
Figure 17. Infectious Disease Drug Discovery Image
Figure 18. Metabolic and Cardiovascular Drug Discovery Image
Figure 19. Other Therapeutic Discovery Image
Figure 20. Global DNA-Encoded Library Screening Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 21. Global DNA-Encoded Library Screening Services Sales Value Share 2021 VS 2025 VS 2032
Figure 22. Global DNA-Encoded Library Screening Services Sales Value Share by Application (2021-2032)
Figure 23. Global DNA-Encoded Library Screening Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 24. Global DNA-Encoded Library Screening Services Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 25. North America DNA-Encoded Library Screening Services Sales Value (2021-2032) & (US$ Million)
Figure 26. North America DNA-Encoded Library Screening Services Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Europe DNA-Encoded Library Screening Services Sales Value (2021-2032) & (US$ Million)
Figure 28. Europe DNA-Encoded Library Screening Services Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Asia-Pacific DNA-Encoded Library Screening Services Sales Value (2021-2032) & (US$ Million)
Figure 30. Asia-Pacific DNA-Encoded Library Screening Services Sales Value Share by Country (%), 2025 VS 2032
Figure 31. South America DNA-Encoded Library Screening Services Sales Value (2021-2032) & (US$ Million)
Figure 32. South America DNA-Encoded Library Screening Services Sales Value Share by Country (%), 2025 VS 2032
Figure 33. Middle East & Africa DNA-Encoded Library Screening Services Sales Value (2021-2032) & (US$ Million)
Figure 34. Middle East & Africa DNA-Encoded Library Screening Services Sales Value Share by Country (%), 2025 VS 2032
Figure 35. USA DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. USA DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. USA DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Canada DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Canada DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Canada DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Mexico DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Mexico DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Mexico DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. Germany DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. Germany DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. Germany DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. France DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. France DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. France DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. U.K. DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. U.K. DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. U.K. DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Italy DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Italy DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Italy DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Spain DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Spain DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Spain DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Russia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Russia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Russia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Netherlands DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Netherlands DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Netherlands DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. Nordic Countries DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. Nordic Countries DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. Nordic Countries DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. China DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. China DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. China DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. Japan DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. Japan DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. Japan DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. South Korea DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. South Korea DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. South Korea DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. India DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. India DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. India DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Australia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Australia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Australia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Southeast Asia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Southeast Asia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Southeast Asia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Brazil DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Brazil DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Brazil DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Argentina DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Argentina DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Argentina DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Chile DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Chile DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Chile DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Colombia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Colombia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Colombia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Peru DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Peru DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Peru DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Saudi Arabia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Saudi Arabia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. Israel DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. Israel DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. Israel DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. UAE DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. UAE DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. UAE DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Turkey DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Turkey DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Turkey DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Iran DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Iran DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Iran DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Egypt DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 117. Egypt DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 118. Egypt DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 119. Years Considered
Figure 120. Research Process
Figure 121. Key Executives Interviewed
Scope & coverage.
Types
- Provider-Owned Library Screening
- Client-Provided Library Screening
- Custom-Built Library Screening
- Consortium or Shared-Access Library Screening
Applications
- Oncology Drug Discovery
- Immunology and Inflammation Drug Discovery
- Neurology Drug Discovery
- Infectious Disease Drug Discovery
- Metabolic and Cardiovascular Drug Discovery
- Other Therapeutic Discovery
Companies covered
- Pharmaron
- Vipergen
- Novalix
- DyNAbind
- MedChemExpress
- BioDuro-Sundia
- Charles River Laboratories
- Chemspace
- X-Chem
- HitGen
- WuXi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global DNA-Encoded Library Screening Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global DNA-Encoded Library Screening Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 DNA-Encoded Library Screening Services Market Dynamics
- 2.1 DNA-Encoded Library Screening Services Industry Trends
- 2.2 DNA-Encoded Library Screening Services Industry Drivers
- 2.3 DNA-Encoded Library Screening Services Industry Opportunities and Challenges
- 2.4 DNA-Encoded Library Screening Services Industry Restraints
3 DNA-Encoded Library Screening Services Market by Company
- 3.1 Global DNA-Encoded Library Screening Services Company Revenue Ranking in 2025
- 3.2 Global DNA-Encoded Library Screening Services Revenue by Company (2021-2026)
- 3.3 Global DNA-Encoded Library Screening Services Company Ranking (2024-2026)
- 3.4 Global DNA-Encoded Library Screening Services Company Manufacturing Base and Headquarters
- 3.5 Global DNA-Encoded Library Screening Services Company Product Type and Application
- 3.6 Global DNA-Encoded Library Screening Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global DNA-Encoded Library Screening Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 DNA-Encoded Library Screening Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 DNA-Encoded Library Screening Services Market by Type
- 4.1 DNA-Encoded Library Screening Services Type Introduction
- 4.1.1 Provider-Owned Library Screening
- 4.1.2 Client-Provided Library Screening
- 4.1.3 Custom-Built Library Screening
- 4.1.4 Consortium or Shared-Access Library Screening
- 4.2 Global DNA-Encoded Library Screening Services Sales Value by Type
- 4.2.1 Global DNA-Encoded Library Screening Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global DNA-Encoded Library Screening Services Sales Value by Type (2021-2032)
- 4.2.3 Global DNA-Encoded Library Screening Services Sales Value Share by Type (2021-2032)
5 DNA-Encoded Library Screening Services Market by Application
- 5.1 DNA-Encoded Library Screening Services Application Introduction
- 5.1.1 Oncology Drug Discovery
- 5.1.2 Immunology and Inflammation Drug Discovery
- 5.1.3 Neurology Drug Discovery
- 5.1.4 Infectious Disease Drug Discovery
- 5.1.5 Metabolic and Cardiovascular Drug Discovery
- 5.1.6 Other Therapeutic Discovery
- 5.2 Global DNA-Encoded Library Screening Services Sales Value by Application
- 5.2.1 Global DNA-Encoded Library Screening Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global DNA-Encoded Library Screening Services Sales Value by Application (2021-2032)
- 5.2.3 Global DNA-Encoded Library Screening Services Sales Value Share by Application (2021-2032)
6 DNA-Encoded Library Screening Services Regional Value Analysis
- 6.1 Global DNA-Encoded Library Screening Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global DNA-Encoded Library Screening Services Sales Value by Region (2021-2032)
- 6.2.1 Global DNA-Encoded Library Screening Services Sales Value by Region: 2021-2026
- 6.2.2 Global DNA-Encoded Library Screening Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America DNA-Encoded Library Screening Services Sales Value (2021-2032)
- 6.3.2 North America DNA-Encoded Library Screening Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe DNA-Encoded Library Screening Services Sales Value (2021-2032)
- 6.4.2 Europe DNA-Encoded Library Screening Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific DNA-Encoded Library Screening Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific DNA-Encoded Library Screening Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America DNA-Encoded Library Screening Services Sales Value (2021-2032)
- 6.6.2 South America DNA-Encoded Library Screening Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa DNA-Encoded Library Screening Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa DNA-Encoded Library Screening Services Sales Value Share by Country, 2025 VS 2032
7 DNA-Encoded Library Screening Services Country-level Value Analysis
- 7.1 Global DNA-Encoded Library Screening Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global DNA-Encoded Library Screening Services Sales Value by Country (2021-2032)
- 7.2.1 Global DNA-Encoded Library Screening Services Sales Value by Country (2021-2026)
- 7.2.2 Global DNA-Encoded Library Screening Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt DNA-Encoded Library Screening Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt DNA-Encoded Library Screening Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt DNA-Encoded Library Screening Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Pharmaron
- 8.1.1 Pharmaron Company Information
- 8.1.2 Pharmaron Business Overview
- 8.1.3 Pharmaron DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Pharmaron DNA-Encoded Library Screening Services Product Portfolio
- 8.1.5 Pharmaron Recent Developments
- 8.2 Vipergen
- 8.2.1 Vipergen Company Information
- 8.2.2 Vipergen Business Overview
- 8.2.3 Vipergen DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Vipergen DNA-Encoded Library Screening Services Product Portfolio
- 8.2.5 Vipergen Recent Developments
- 8.3 Novalix
- 8.3.1 Novalix Company Information
- 8.3.2 Novalix Business Overview
- 8.3.3 Novalix DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Novalix DNA-Encoded Library Screening Services Product Portfolio
- 8.3.5 Novalix Recent Developments
- 8.4 DyNAbind
- 8.4.1 DyNAbind Company Information
- 8.4.2 DyNAbind Business Overview
- 8.4.3 DyNAbind DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.4.4 DyNAbind DNA-Encoded Library Screening Services Product Portfolio
- 8.4.5 DyNAbind Recent Developments
- 8.5 MedChemExpress
- 8.5.1 MedChemExpress Company Information
- 8.5.2 MedChemExpress Business Overview
- 8.5.3 MedChemExpress DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.5.4 MedChemExpress DNA-Encoded Library Screening Services Product Portfolio
- 8.5.5 MedChemExpress Recent Developments
- 8.6 BioDuro-Sundia
- 8.6.1 BioDuro-Sundia Company Information
- 8.6.2 BioDuro-Sundia Business Overview
- 8.6.3 BioDuro-Sundia DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.6.4 BioDuro-Sundia DNA-Encoded Library Screening Services Product Portfolio
- 8.6.5 BioDuro-Sundia Recent Developments
- 8.7 Charles River Laboratories
- 8.7.1 Charles River Laboratories Company Information
- 8.7.2 Charles River Laboratories Business Overview
- 8.7.3 Charles River Laboratories DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Charles River Laboratories DNA-Encoded Library Screening Services Product Portfolio
- 8.7.5 Charles River Laboratories Recent Developments
- 8.8 Chemspace
- 8.8.1 Chemspace Company Information
- 8.8.2 Chemspace Business Overview
- 8.8.3 Chemspace DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Chemspace DNA-Encoded Library Screening Services Product Portfolio
- 8.8.5 Chemspace Recent Developments
- 8.9 X-Chem
- 8.9.1 X-Chem Company Information
- 8.9.2 X-Chem Business Overview
- 8.9.3 X-Chem DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.9.4 X-Chem DNA-Encoded Library Screening Services Product Portfolio
- 8.9.5 X-Chem Recent Developments
- 8.10 HitGen
- 8.10.1 HitGen Company Information
- 8.10.2 HitGen Business Overview
- 8.10.3 HitGen DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.10.4 HitGen DNA-Encoded Library Screening Services Product Portfolio
- 8.10.5 HitGen Recent Developments
- 8.11 WuXi AppTec
- 8.11.1 WuXi AppTec Company Information
- 8.11.2 WuXi AppTec Business Overview
- 8.11.3 WuXi AppTec DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 8.11.4 WuXi AppTec DNA-Encoded Library Screening Services Product Portfolio
- 8.11.5 WuXi AppTec Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst